mRNA |
simvastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.005 |
mRNA |
azacitidine |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
-0.14 |
0.006 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.007 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.007 |
mRNA |
LRRK2-IN-1 |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.008 |
mRNA |
ZM-447439 |
GDSC1000 |
pan-cancer |
AAC |
-0.091 |
0.01 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.01 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.01 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.01 |